Opko Health OPK
NASDAQ OPK
$1.50 -0.01 (-0.99%)
As of: Aug 27, 2026 · 3:59 PM EDT

Opko Health (OPK) Restructuring Costs (2012 - 2013)

Opko Health's (OPK) quarterly Restructuring Costs came in at $2.6 million in Q2 2013, up 167.05% YoY from $965000.0 in Q2 2012, and up 91.74% on a QoQ basis from $1.3 million in Q1 2013.

Opko Health (OPK) Restructuring Costs (2012 - 2013) Analysis & Trends

Opko Health (OPK) has 2 years of Restructuring Costs data on file, last reported at $2.6 million in Q2 2013.

  • Quarterly Restructuring Costs rose 167.05% year-over-year to $2.6 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $2.6 million (changed N/A YoY) and the FY2012 annual result came in at $785000.0, changed N/A from the prior year.
  • Restructuring Costs rose to $2.6 million in Q2 2013, from $1.3 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $2.6 million in Q2 2013 to a low of -$1.9 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Opko Health 1.13 Bn 824.59 Mn 80.02 Mn

Historic Data

Download Data
DateValue
Jun 30, 2013 2.58 Mn
Mar 31, 2013 1.34 Mn
Dec 31, 2012 -1.88 Mn
Sep 30, 2012 556,000.00
Jun 30, 2012 965,000.00
Mar 31, 2012 1.14 Mn